R&D Vision·Strategy
Boryung – Walking a Single Path for 50 Years, Envisioning a Healthy World
R&D Vision
Boryung Pursues Continuously Enhancing Innovation
Lifetime Care Company
Boryung contributes to the health of mankind through corporate philosophy on interdependence based on humanism and coexistence management. We are unceasingly implementing new research activity to uphold our corporate philosophy.
Above all, Boryung is focused on developing medicine that contributes to the improvement of a patient’s quality of life, and it is on this foundation that we hope to develop into a global pharmaceutical company.
R&D Strategy
Contributing to the Development of the Pharmaceutical Industry through the Spirit of Interdependence
First in Class
Boryung is fulfilling the global License out and growing into a global pharmaceutical company through our drug development, which aims at being First in Class, development of the Kanarb Value-up Pipeline that is centered on the hypertension drug, “Kanarb”, and development of various IMDs to fulfill unmet needs.
136, Changgyeonggung-ro, Jongno-gu, Seoul, Republic of Korea (03127)
Copyright (C) 2022 by Boryung Pharmaceutical Co.,Ltd. All Rights Reserved.
